Isoprenoid biosynthesis in Plasmodium falciparum.

Area of Science:

• Parasitology
• Biochemistry
• Drug Discovery

Background:

• Malaria remains a significant global health threat, with Plasmodium falciparum developing resistance to existing treatments.
• Isoprenoid biosynthesis, particularly via the methylerythritol phosphate (MEP) pathway, is crucial for parasite survival and represents a promising therapeutic target.

Purpose of the Study:

• To review the known functions and regulation of isoprenoid synthesis in P. falciparum.
• To identify future research directions for developing new antimalarial drugs targeting this pathway.

Main Methods:

• Literature review of isoprenoid biosynthesis and its inhibition in P. falciparum.
• Analysis of the role of fosmidomycin as an isoprenoid synthesis inhibitor.
• Examination of the regulation of isoprenoid synthesis by sugar phosphatases.

Main Results:

• Isoprenoids are essential for P. falciparum, involved in tRNA and protein prenylation, and synthesis of vital molecules like ubiquinone and vitamin E.
• Fosmidomycin effectively inhibits isoprenoid synthesis, demonstrating its utility in studying the MEP pathway.
• Emerging evidence points to sugar phosphatases as key regulators of isoprenoid synthesis in the parasite.

Conclusions:

• The MEP pathway and its products are critical for P. falciparum viability, making them attractive targets for novel antimalarial drug development.
• Further research into the regulation and specific enzymes of the isoprenoid pathway can uncover new therapeutic strategies against malaria.